Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2023-09-06 Major Shareholding Noti…
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Form 8.3 - Dechra Pharmaceuticals plc
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'FORM 8.3 - PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is used by parties involved in a takeover bid to disclose their interests and dealings in the relevant securities. This type of disclosure relates to insider transactions or significant ownership changes during a takeover scenario. Among the provided codes, 'DIRS' (Director's Dealing) is the closest fit for insider/significant shareholder transaction reporting, although this specific form (Form 8.3) is highly specialized for takeover activity. Since there is no specific code for 'Takeover Disclosure Form 8.3', and it involves reporting personal/firm dealings in securities, 'DIRS' is the most appropriate classification, as it covers personal share transactions by executives/insiders, which this disclosure effectively is, albeit under takeover rules. Alternatively, 'MRQ' (Major Shareholding Notification) could be considered, but DIRS better captures the 'dealing' aspect emphasized in the form title. Given the context of the Takeover Code, this is a specific type of insider/major shareholder disclosure, making DIRS the best fit among the options for reporting security interests and dealings.
2023-09-06 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and is issued via 'RNS Number'. It details an acquisition of voting rights by Societe Generale, crossing a threshold, and reports the resulting total positions (7.229300%). This structure perfectly matches the definition of a Major Shareholding Notification, which is classified under the code MRQ in the provided schema. Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2023-09-06 English
Form 8.3 - Dechra Pharmaceuticals plc
Major Shareholding Notification Classification · 98% confidence The document is explicitly titled "FORM 8.3" and references "Rule 8.3 of the Takeover Code (the 'Code')". This form is a Public Opening Position Disclosure or Dealing Disclosure made by a person holding 1% or more interest in securities relevant to a takeover offer. This type of filing relates to insider transactions or significant ownership changes during a takeover scenario. Among the provided codes, 'DIRS' (Director's Dealing) is the closest fit as it covers personal share transactions by executives/insiders, although Form 8.3 is specifically mandated by the UK Takeover Code for parties involved in an offer. Since there is no specific code for 'Takeover Code Disclosure', and this document details interests and dealings of a major shareholder (Millennium International Management LP) in relation to an offer for Dechra Pharmaceuticals plc, it falls under the broader category of insider/significant shareholder transaction reporting. 'DIRS' is the most appropriate classification for insider trading/dealing disclosures, even though this is a specific regulatory form (Form 8.3) rather than a standard director's dealing report.
2023-09-05 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 4489L' and contains the standard boilerplate language indicating it is distributed by 'RNS, the news service of the London Stock Exchange.' The content itself is a 'TR-1: Standard form for notification of major holdings' filed by Societe Generale regarding an acquisition of voting rights in Dechra Pharmaceuticals PLC, crossing a threshold. This type of mandatory disclosure regarding significant changes in share ownership is specifically covered by the 'Major Shareholding Notification' definition. Although RNS is mentioned, the content is a specific regulatory filing (TR-1) about share ownership changes, which maps directly to the 'Major Shareholding Notification' code (MRQ), rather than being a general announcement (RNS) or a report itself (like 10-K or IR).
2023-09-05 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with "RNS Number : 4208L" and contains the standard format for a major holding notification, specifically "TR-1: Standard form for notification of major holdings". This form details an acquisition or disposal of voting rights by a shareholder (Societe Generale) crossing a threshold. This type of filing, which reports changes in significant share ownership, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2023-09-05 English
Form 8.3 - Dechra Pharmaceuticals plc
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled "FORM 8.3 - Dechra Pharmaceuticals plc" and references "Rule 8.3 of the Takeover Code (the “Code”)". Form 8.3 disclosures relate to a person with interests (or short positions) of 1% or more in relevant securities during a takeover offer. This type of filing is a specific regulatory disclosure concerning insider/significant shareholder dealings during a takeover scenario. While it involves dealings, it is not a general Director's Dealing report (DIRS) but a specific filing mandated by the Takeover Code. In the provided list, there is no direct code for a 'Takeover Code Disclosure Form 8.3'. However, such filings are mandatory regulatory disclosures related to corporate actions (takeovers). Given the options, the closest fit for a specific, mandatory regulatory filing that isn't a standard periodic report (10-K, IR) or a general announcement (RNS) is difficult. Since it details dealings and interests during a potential M&A event (implied by the Takeover Code reference), it relates closely to M&A Activity (TAR). However, Form 8.3 is fundamentally a disclosure of personal/fund dealings. Since 'Director's Dealing' (DIRS) covers personal share transactions by executives, and this is a similar concept (insider/significant holder dealing disclosure) under specific M&A rules, DIRS is a plausible category if we interpret it broadly as 'insider dealing disclosure'. If we must strictly adhere to the definitions, this is a specific regulatory filing related to a takeover. Since the document details dealings and interests (Section 2 and 3), and the context is a takeover (Rule 8.3 of the Takeover Code), it is most closely related to M&A Activity (TAR) or a specific type of insider dealing (DIRS). Given the explicit reference to the Takeover Code and the nature of the disclosure (position disclosure/dealing disclosure by a person with interests in relevant securities), it is a specialized filing. Since the document details the holdings and dealings of an interested party during a potential takeover, it falls under the scope of M&A Activity (TAR) or a specific insider dealing report. As it is a mandatory disclosure related to a takeover situation, TAR is a strong candidate, but DIRS (Director's Dealing) covers personal share transactions by executives/insiders. Since this is a major shareholder/fund manager disclosure under takeover rules, it is a form of insider dealing disclosure. Given the options, and the fact that it is a disclosure of personal/fund dealings, DIRS is the most appropriate fit among the provided choices for a dealing disclosure, even though it's specific to the Takeover Code context.
2023-09-04 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.